1.
Said DG, Otri M, Miri A, Kailasanathan A, Khatib T, Dua HS: The challenge of fungal keratitis. The British journal of ophthalmology 2011, 95(12):1623-1624.
2.
Murphy MB, Moncivais K, Caplan AI: Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Experimental & molecular medicine 2013, 45:e54.
3.
Yao L, Li ZR, Su WR, Li YP, Lin ML, Zhang WX, Liu Y, Wan Q, Liang D: Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn. PloS one 2012, 7(2):e30842.
4.
Rajendran V, Netukova M, Griffith M, Forrester JV, Kuffova L: Mesenchymal stem cell therapy for retro-corneal membrane - A clinical challenge in
full-thickness transplantation of biosynthetic corneal equivalents. Acta biomaterialia 2017, 64:346-356.
5.
Xu J, Wang D, Liu D, Fan Z, Zhang H, Liu O, Ding G, Gao R, Zhang C, Ding Y et al: Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren
syndrome. Blood 2012, 120(15):3142-3151.
6.
Zhang H, Wang L, Li Z, Liu S, Xie Y, He S, Deng X, Yang B, Liu H, Chen G et al: A novel murine model of Fusarium solani keratitis utilizing fluorescent labeled fungi. Experimental eye research 2013, 110:107-112.
7.
Zhang H, Wang L, Liu S, Xie Y, Deng X, He S, Zhang J, Sun S, Li X, Li Z: Two-photon imaging of the cornea visualized in the living mouse using vital dyes. Invest Ophthalmol Vis Sci 2013, 54(10):6526-6536.
8.
Xuan J, Feng W, An ZT, Yang J, Xu HB, Li J, Zhao ZF, Wen W: Anti-TGFbeta-1 receptor inhibitor mediates the efficacy of the human umbilical cord
mesenchymal stem cells against liver fibrosis through TGFbeta-1/Smad pathway. Molecular and cellular biochemistry 2017, 429(1-2):113-122.
9.
Torricelli AA, Santhanam A, Wu J, Singh V, Wilson SE: The corneal fibrosis response to epithelial-stromal injury. Experimental eye research 2016, 142:110-118.
10.
Funderburgh JL, Mann MM, Funderburgh ML: Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal
fibrosis. The Journal of biological chemistry 2003, 278(46):45629-45637.
11.
Foster J, Wu WH, Scott SG, Bassi M, Mohan D, Daoud Y, Stark WJ, Jun AS, Chakravarti
S: Transforming growth factor beta and insulin signal changes in stromal fibroblasts
of individual keratoconus patients. PloS one 2014, 9(9):e106556.
12.
Zhou H-Y, Cao Y, Wu J, Zhang W-S: Role of corneal collagen fibrils in corneal disorders and related pathological conditions. International journal of ophthalmology 2017, 10(5):803-811.
13.
Medeiros CS, Marino GK, Santhiago MR, Wilson SE: The Corneal Basement Membranes and Stromal Fibrosis. Investigative ophthalmology & visual science 2018, 59(10):4044-4053.
14.
Lee MJ, Ko AY, Ko JH, Lee HJ, Kim MK, Wee WR, Khwarg SI, Oh JY: Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation
in an experimental dry eye. Mol Ther 2015, 23(1):139-146.
15.
Ke Y, Wu Y, Cui X, Liu X, Yu M, Yang C, Li X: Polysaccharide hydrogel combined with mesenchymal stem cells promotes the healing
of corneal alkali burn in rats. PloS one 2015, 10(3):e0119725.
16.
Murphy N, Lynch K, Lohan P, Treacy O, Ritter T: Mesenchymal stem cell therapy to promote corneal allograft survival: current status
and pathway to clinical translation. Current opinion in organ transplantation 2016, 21(6):559-567.
17.
Coulson-Thomas VJ, Caterson B, Kao WW: Transplantation of human umbilical mesenchymal stem cells cures the corneal defects
of mucopolysaccharidosis VII mice. Stem cells 2013, 31(10):2116-2126.
18.
Liu H, Zhang J, Liu CY, Wang IJ, Sieber M, Chang J, Jester JV, Kao WW: Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells:
lumican null mice. PloS one 2010, 5(5):e10707.
19.
Arutyunyan I, Elchaninov A, Makarov A, Fatkhudinov T: Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy. Stem cells international 2016, 2016:6901286-6901286.
20.
Fang S, Xu C, Zhang Y, Xue C, Yang C, Bi H, Qian X, Wu M, Ji K, Zhao Y et al: Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast
Differentiation by Inhibiting the Transforming Growth Factor-beta/SMAD2 Pathway During
Wound Healing. Stem cells translational medicine 2016, 5(10):1425-1439.
21.
Du Y, Carlson EC, Funderburgh ML, Birk DE, Pearlman E, Guo N, Kao WW, Funderburgh
JL: Stem cell therapy restores transparency to defective murine corneas. Stem cells 2009, 27(7):1635-1642.
22.
Heidari B, Shirazi A, Akhondi MM, Hassanpour H, Behzadi B, Naderi MM, Sarvari A, Borjian
S: Comparison of proliferative and multilineage differentiation potential of sheep mesenchymal
stem cells derived from bone marrow, liver, and adipose tissue. Avicenna journal of medical biotechnology 2013, 5(2):104-117.
23.
Lee RH, Yu JM, Foskett AM, Peltier G, Reneau JC, Bazhanov N, Oh JY, Prockop DJ: TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells
(hMSCs) in modulating sterile inflammation in vivo. Proc Natl Acad Sci U S A 2014, 111(47):16766-16771.
24.
Marote A, Teixeira FG, Mendes-Pinheiro B, Salgado AJ: MSCs-Derived Exosomes: Cell-Secreted Nanovesicles with Regenerative Potential. Front Pharmacol 2016, 7:231.
25.
Yu B, Shao H, Su C, Jiang Y, Chen X, Bai L, Zhang Y, Li Q, Zhang X, Li X: Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition
of MCP-1. Scientific reports 2016, 6:34562-34562.